Penn Medicine's renowned GI research program receives the most funding from the National Institutes of Health (NIH) of any program in the country. Clinical programs benefit from the largest group of specialists in digestive, liver and pancreatic diseases in the greater Philadelphia region, bringing a breadth of expertise that ensures comprehensive and innovative care.
Bio-medical research is conducted at the Center for Molecular Studies in Digestive and Liver Disease with an aim to:
- Enhance GI treatment techniques to optimize patient outcomes
- Develop innovative and promising clinical trials for patients with GI diseases
- Further enrich and enhance GI clinical programs
- Enable future leaders in medicine to pioneer the latest technological advancements in the field of gastroenterology
The University of Pennsylvania ranks among the top five U.S. academic medical centers in NIH funding, and U.S. News & World Report ranked the Perelman School of Medicine third in the nation for medical schools.